Iodinated Contrast Media and the Alleged "Iodine Allergy": An Inexact Diagnosis Leading to Inferior Radiologic Management and Adverse Drug Reactions.

Purpose To test the hypothesis that the incomplete diagnosis "iodine allergy" is a possibly dangerous concept for patients under routine radiologic conditions. Materials and Methods 300 patients with a history of an "iodine allergy" were retrospectively screened and compared with two age-, sex-, and procedure-matched groups of patients either diagnosed with a nonspecific "iodine contrast medium (ICM) allergy" or an allergy to a specific ICM agent. For all groups, the clinical symptoms of the most recent past adverse drug reaction (ADR), prophylactic actions taken for subsequent imaging, and ultimate outcome were recorded and analyzed. Results The diagnosis "iodine allergy" was not otherwise specified in 84.3 % patients. For this group, in most cases, the symptoms of the previous ADRs were not documented. In contrast, the type of ADR was undocumented in only a minority of patients in the comparison groups. In the group of patients with an "iodine allergy" the percentage of unenhanced CT scans was greater than within the other two groups (36.7 % vs. 28.7 %/18.6 %). ADRs following prophylactic measures were only observed in the "iodine allergy" group (OR of 9.24 95 % CI 1.16 - 73.45; p < 0.04). Conclusion This data confirms the hypothesis that the diagnosis "iodine allergy" is potentially dangerous and results in uncertainty in clinical management and sometimes even ineffective prophylactic measures. Key points · The term "iodine allergy" is imprecise, because it designates allergies against different substance classes, such as disinfectants with complexed iodine and contrast media containing covalently bound iodine.. · There is a clear correlation between the exactness of the diagnosis - from the alleged "iodine allergy" to "contrast media allergy" to naming the exact culprit CM - and the quality of documentation of the symptoms.. · Management of patients diagnosed with "iodine allergy" was associated with uncertainty leading to unenhanced scans and sometimes unnecessary prophylactic actions.. · The term "iodine allergy" should be omitted, because it is potentially dangerous and can decrease the quality of radiology exams.. Citation Format · Böhm Ingrid, Nairz Knud, Morelli John N et al. Iodinated Contrast Media and the Alleged "Iodine Allergy": An Inexact Diagnosis Leading to Inferior Radiologic Management and Adverse Drug Reactions. Fortschr Röntgenstr 2017; 189: 326 - 332.

Interaction of heterocyclic thiols/thiones eliminated from cephalosporins with iodine and its biological implications.

Hydrolysis of beta-lactam antibiotics by beta-lactamases (e.g., metallo-beta-lactamase, mbetal) is one of the major bacterial defense systems. These enzymes can catalyze the hydrolysis of a variety of antibiotics including the latest generation of cephalosporins, cephamycins and imipenem. It is shown in this paper that the thiol/thione moieties eliminated from certain cephalosporins by mbetal-mediated hydrolysis readily react with molecular iodine to produce ionic compounds having S-I bonds. While the reaction of MTT with iodine produced the corresponding disulfide, MDT and DMETT produced the charge-transfer complexes MDT-I(2) and DMETT-I(2), respectively. Addition of two equivalents of I(2) to MDT produced a novel cationic complex having an almost linear S-I(+)-S moiety and I(5)(-) counter anion. However, this reaction appears to be highly solvent dependent. When the reaction of MDT with I(2) was carried out in water, the reaction produced a monocation having I(5)(-), indicating the reactivity of MDT toward I(2) is very similar to that of the most commonly used antithyroid drug methimazole (MMI). In contrast to MMI, MDT and DMETT, the triazine-based compound MTDT acts as a weak donor toward iodine.

Changes in the regulation of iodine crystals and chemical mixtures containing over 2.2 percent iodine. Final rule.

This rulemaking changes the regulation of the listed chemical iodine under the chemical regulatory provisions of the Controlled Substances Act (CSA). The Drug Enforcement Administration (DEA) believes that this action is necessary to remove deficiencies in the existing regulatory controls, which have been exploited by drug traffickers who divert iodine (in the form of iodine crystals and iodine tincture) for the illicit production of methamphetamine in clandestine drug laboratories. This rulemaking moves iodine from List II to List I; reduces the iodine threshold from 0.4 kilograms to zero kilograms; adds import and export regulatory controls; and controls chemical mixtures containing greater than 2.2 percent iodine. This rulemaking establishes regulatory controls that will apply to iodine crystals and iodine chemical mixtures that contain greater than 2.2 percent iodine. This regulation therefore controls iodine crystals and strong iodine tinctures/solutions (e.g., 7 percent iodine) that do not have common household uses and instead have limited application in livestock, horses, and for disinfection of equipment. Household products such as 2 percent iodine tincture/solution and household disinfectants containing iodine complexes will not be adversely impacted by this regulation. Additionally, the final rule exempts transactions of up to one-fluid-ounce (30 ml) of Lugol's Solution. Persons handling regulated iodine materials are required to register with DEA, are subject to the import/export notification requirements of the CSA, and are required to maintain records of all regulated transactions involving iodine regardless of size.

Further research on iodine speciation in seawater by capillary zone electrophoresis with isotachophoresis preconcentration.

A novel, simple and highly sensitive CE method was developed to determine total iodine (TI) in seawater. The method is based on the on-capillary reduction of iodine species to iodide by a reductant, introduced into the capillary before sample injection, the preconcentration of iodide using isotachophoresis, followed by its UV detection. Under optimized conditions for reduction and CE separation, the limit of detection for TI (S/N = 3) reached 0.4 microg L(-1) (226 nm). The repeatability of migration time and peak area, expressed by relative standard deviation, was 0.46 and 1.45%, respectively (n = 19). The correlation factor was 0.9991 (n = 10) for the concentration range of 12-115 microg I L(-1). The CE results obtained for the real seawater analysis agreed with the data of ion chromatography. To determine the genuine TI by the proposed method, organic iodinated compounds in the sample were treated with H202 and irradiation with UV light before analysis.

El Yodo y sus preparados galénicos

1.El yodo es un elemento de propiedades quimicas tan caracteristicas que sus aplicaciones en laboratorio son numerosas y de importancia, 2.Las propiedades terapeuticas del yodo son igualmente numerosas por lo cual es muy extendido su empleo en medicina, 3.Son los preparados galénicos y especificos del yodo de gran variedad los que tienen aplicacion médica, 4.El farmacéutico debe hacer el despacho de este cuerpo en condiciones de pureza quimica teniendo presente que este y sus derivados son suceptibles de alteraciones peligrosas